Population pharmacokinetics of phenobarbital by mixed effect modelling using routine clinical pharmacokinetic data in Japanese neonates and infants: An update

Journal of Clinical Pharmacy and Therapeutics

Volumn 36, Issue 6, 2011, Pages 704-710

  Yukawa, M ^a   Yukawa, E ^b   Suematsu, F ^c   Takiguchi, T ^b   Ikeda, H ^a   Aki, H ^a   Mimemoto, M ^d  

^a FUKUOKA UNIVERSITY   (Japan)

^b DAIICHI UNIVERSITY OF PHARMACY   (Japan)

^c Yufuin Kosei Nenkin Hospital   (France)

^d KYUSHU KOSEI NENKIN HOSPITAL   (Japan)

Author keywords

infants; neonates; non linear mixed effects model; phenobarbital; population pharmacokinetics

Indexed keywords

PHENOBARBITAL;

ARTICLE; BODY WEIGHT; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG MONITORING; FEMALE; GENDER; GESTATIONAL AGE; HUMAN; INFANT; JAPANESE; MAJOR CLINICAL STUDY; MALE; NEWBORN; PHARMACOKINETICS;

AGE FACTORS; ANTICONVULSANTS; ASIAN CONTINENTAL ANCESTRY GROUP; BODY WEIGHT; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG MONITORING; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; JAPAN; MALE; MODELS, BIOLOGICAL; NONLINEAR DYNAMICS; PHENOBARBITAL; RETROSPECTIVE STUDIES;

EID: 80055056538     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2010.01220.x     Document Type: Article

References (14)

1. Boer HR, Gal P, (1982) Neonatal seizures: a survey of current practice. Clinical Pediatrics, 21, 453-457. (Pubitemid 12099880)
2. Wallin A, Jalling B, Boreus LO, (1974) Plasma concentrations of phenobarbital in the neonate during prophylaxis for neonatal hyperbilirubinemia. Journal of Pediatrics, 85, 392-397.
3. Yukawa E, Suematsu F, Yukawa M, et al. (2005) Population pharmacokinetics of phenobarbital by mixed effect modeling using routine clinical pharmacokinetic data in Japanese neonates and infants. Journal of Clinical Pharmacy and Therapeutics, 30, 159-163. (Pubitemid 41583611)
4. Beal SL, Sheiner LB, eds (1992) NONMEM user's guides. NONMEM Project Group, San Francisco, CA: University of California at San Francisco.
5. Sheiner LB, Beal SL, (1981) Some suggestions for measuring predictive performance. Journal of Pharmacokinetics and Biopharmaceutics, 9, 503-512.
6. Grasela TH Jr, Donn SM, (1985) Neonatal population pharmacokinetics of phenobarbital derived from routine clinical data. Developmental Pharmacology and Therapeutics, 8, 374-383. (Pubitemid 16204067)
7. Fischer JH, Lockman LA, Zaske D, et al. (1981) Phenobarbital maintenance dose requirements in treating neonatal seizures. Neurology, 31, 1042-1044. (Pubitemid 11061750)
8. Battino D, Estienne M, Avanzini G, (1995) Clinical pharmacokinetics of antiepileptic drugs in paediatric patients. Part I: phenobarbital, primidone, valproic acid, ethosuximide and mesuximide. Clinical Pharmacokinetics, 29, 257-286.
9. Dodson WE, Rust RS Jr, (1995) Phenobarbital. Absorption, distribution, and excretion. In:, Levy RH, Mattson RH, Meldrum BS, eds. Antiepi-leptic drugs, 4th edn. New York: Raven Press, 379-387.
10. Morselli PL, (1976) Clinical pharmacokinetics in neonates. Clinical Pharmacokinetics, 1, 81-98.
11. Lockman LA, Kriel R, Zaske D, et al. (1979) Phenobarbital dosage for control of neonatal seizures. Neurology, 29, 1445-1449. (Pubitemid 10228577)
12. Pitlick W, Painter M, Pippenger CE, (1978) Phenobarbital pharmacokinetics in neonates. Clinical Pharmacology and Therapeutics, 23, 346-350. (Pubitemid 8302192)
13. Jalling B, (1975) Plasma concentrations of phenobarbital in the treatment of seizures in newborns. Acta Paediatrica Scandinavica, 64, 514-524.
14. Viswanathan CT, Booker HE, Welling PG, (1978) Bioavailability of oral and intramuscular phenobarbital. Journal of Clinical Pharmacology, 18, 100-105. (Pubitemid 8305290)